BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 20385113)

  • 1. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.
    Chen DY; Tzang BS; Chen YM; Lan JL; Tsai CC; Hsu TC
    Clin Chim Acta; 2010 Aug; 411(15-16):1084-9. PubMed ID: 20385113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
    Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
    Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
    Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Tsai CC; Chiu CC; Shi JY; Hsu TC
    Clin Chim Acta; 2008 Sep; 395(1-2):77-83. PubMed ID: 18538665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome.
    Lin CY; Chiu CC; Cheng J; Lin CY; Shi YF; Tsai CC; Tzang BS; Hsu TC
    Virulence; 2018 Jan; 9(1):208-216. PubMed ID: 28960143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.
    Chen DY; Chen YM; Lan JL; Tzang BS; Lin CC; Hsu TC
    Clin Chim Acta; 2012 May; 413(9-10):855-60. PubMed ID: 22309679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Lin TM; Tsai CC; Hsu JD; Yang LC; Hsu TC
    Mol Immunol; 2011 Jul; 48(12-13):1518-24. PubMed ID: 21555155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W; Halim MA; Al-Nakib W
    Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.
    Tzang BS; Tsai CC; Tsay GJ; Wang M; Sun YS; Hsu TC
    Clin Chim Acta; 2009 Jul; 405(1-2):76-82. PubMed ID: 19362081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
    Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
    Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.